By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Interleukin Genetics announced after the close of the market Thursday that revenues for the third quarter rose 41 percent year over year.

Total revenues increased to $765,416 for the three months ended Sept. 30, from $544,744 a year ago, as genetic testing service revenue rose 38 percent to $731,194 from $531,151. Other revenues came in at $34,222, up 152 percent from $13,593 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.